胸腺瘤相关性慢性腹泻:自身免疫性肠病1例

Patricio Riquelme , Alison H. Tisch , Ying Liang , Anson W. Lowe , Alexander D. Colevas , Heather A. Wakelee
{"title":"胸腺瘤相关性慢性腹泻:自身免疫性肠病1例","authors":"Patricio Riquelme ,&nbsp;Alison H. Tisch ,&nbsp;Ying Liang ,&nbsp;Anson W. Lowe ,&nbsp;Alexander D. Colevas ,&nbsp;Heather A. Wakelee","doi":"10.1016/j.ctrc.2015.04.002","DOIUrl":null,"url":null,"abstract":"<div><p>Thymomas are tumors arising from thymic epithelial cells that are frequently associated with autoimmune conditions. One such disorder, autoimmune enteropathy, is an uncommon autoimmune process found in patients with thymoma that is characterized by chronic diarrhea (&gt;6 weeks duration), malabsorption, and characteristic small intestinal histopathology. The presence of anti-enterocyte or anti-goblet cell antibodies supports the diagnosis of autoimmune. As this is a relatively uncommon disorder, treatment options have not been well studied. We report the case of a 35-year-old Caucasian male with recurrent thymoma that subsequently developed autoimmune enteropathy as confirmed by symptoms, biopsy and serologies. Prednisone and octreotide, which have previously been shown to treat recurrent thymoma, were used to successfully treat his autoimmune enteropathy and recurrent thymoma, leading to resolution of diarrhea, subsequent weight gain, and radiographic confirmation of regression of metastatic thymoma. Autoimmune enteropathy should be considered in the differential diagnosis of patients with thymoma presenting with intractable diarrhea and weight loss. The use of prednisone and octreotide may be helpful in treating both conditions.</p></div>","PeriodicalId":90461,"journal":{"name":"Cancer treatment communications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ctrc.2015.04.002","citationCount":"0","resultStr":"{\"title\":\"Thymoma-associated chronic diarrhea: A case of autoimmune enteropathy\",\"authors\":\"Patricio Riquelme ,&nbsp;Alison H. Tisch ,&nbsp;Ying Liang ,&nbsp;Anson W. Lowe ,&nbsp;Alexander D. Colevas ,&nbsp;Heather A. Wakelee\",\"doi\":\"10.1016/j.ctrc.2015.04.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Thymomas are tumors arising from thymic epithelial cells that are frequently associated with autoimmune conditions. One such disorder, autoimmune enteropathy, is an uncommon autoimmune process found in patients with thymoma that is characterized by chronic diarrhea (&gt;6 weeks duration), malabsorption, and characteristic small intestinal histopathology. The presence of anti-enterocyte or anti-goblet cell antibodies supports the diagnosis of autoimmune. As this is a relatively uncommon disorder, treatment options have not been well studied. We report the case of a 35-year-old Caucasian male with recurrent thymoma that subsequently developed autoimmune enteropathy as confirmed by symptoms, biopsy and serologies. Prednisone and octreotide, which have previously been shown to treat recurrent thymoma, were used to successfully treat his autoimmune enteropathy and recurrent thymoma, leading to resolution of diarrhea, subsequent weight gain, and radiographic confirmation of regression of metastatic thymoma. Autoimmune enteropathy should be considered in the differential diagnosis of patients with thymoma presenting with intractable diarrhea and weight loss. The use of prednisone and octreotide may be helpful in treating both conditions.</p></div>\",\"PeriodicalId\":90461,\"journal\":{\"name\":\"Cancer treatment communications\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.ctrc.2015.04.002\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer treatment communications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S221308961500016X\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S221308961500016X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

胸腺瘤是由胸腺上皮细胞引起的肿瘤,通常与自身免疫性疾病有关。其中一种疾病,自身免疫性肠病,是一种罕见的自身免疫性过程,常见于胸腺瘤患者,其特征是慢性腹泻(持续6周)、吸收不良和特征性小肠组织病理学。抗肠细胞或抗杯状细胞抗体的存在支持自身免疫性的诊断。由于这是一种相对罕见的疾病,治疗方案还没有得到很好的研究。我们报告一例35岁白人男性复发性胸腺瘤,随后发展为自身免疫性肠病,经症状,活检和血清学证实。强的松和奥曲肽,先前已被证明可以治疗复发性胸腺瘤,成功地治疗了他的自身免疫性肠病和复发性胸腺瘤,导致腹泻消退,随后体重增加,并证实转移性胸腺瘤消退。以难治性腹泻和体重减轻为表现的胸腺瘤患者的鉴别诊断应考虑自身免疫性肠病。使用强的松和奥曲肽可能有助于治疗这两种情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Thymoma-associated chronic diarrhea: A case of autoimmune enteropathy

Thymomas are tumors arising from thymic epithelial cells that are frequently associated with autoimmune conditions. One such disorder, autoimmune enteropathy, is an uncommon autoimmune process found in patients with thymoma that is characterized by chronic diarrhea (>6 weeks duration), malabsorption, and characteristic small intestinal histopathology. The presence of anti-enterocyte or anti-goblet cell antibodies supports the diagnosis of autoimmune. As this is a relatively uncommon disorder, treatment options have not been well studied. We report the case of a 35-year-old Caucasian male with recurrent thymoma that subsequently developed autoimmune enteropathy as confirmed by symptoms, biopsy and serologies. Prednisone and octreotide, which have previously been shown to treat recurrent thymoma, were used to successfully treat his autoimmune enteropathy and recurrent thymoma, leading to resolution of diarrhea, subsequent weight gain, and radiographic confirmation of regression of metastatic thymoma. Autoimmune enteropathy should be considered in the differential diagnosis of patients with thymoma presenting with intractable diarrhea and weight loss. The use of prednisone and octreotide may be helpful in treating both conditions.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Oral chemotherapy in advanced breast cancer: expert perspectives on its role in clinical practice Activity of trastuzumab-emtansine (TDM1) in HER2-positive breast cancer brain metastases: A case series Pigmentation of the tongue with lapatinib treatment in a patient with advanced breast cancer: A case report Assessment of chemotherapy strategy using bevacizumab for non-squamous non-small cell lung cancer in a real-world setting: A multi-institutional observational study Multiple nodular lung metastases with no obvious primary showing low positive 18-fluoro deoxyglucose (FDG) uptake on positron emission tomography (PET) scan: A unique case of metastatic ameloblastoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1